Download PDF
Semin Thromb Hemost 2000; 26(5): 589-594
DOI: 10.1055/s-2000-13215
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Hepatic Microvascular Responses to Sepsis

Axel Ring, Wolfgang Stremmel
  • Department of Medicine IV, University of Heidelberg, Heidelberg, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

The liver is believed to play a major role in the initiation of multiorgan failure, the most lethal complication in the clinical course of sepsis. Microbes and their virulence factors enter the hepatic circulation where they first activate sinusoidal endothelial cells and Kupffer cells to produce proinflammatory mediators, including TNF-α, IL-1, IL-6, reactive oxygen metabolites, and eicosanoids. These mediators cause not only microbial killing, but also structural and functional liver damage concerning mainly the parenchymal cells. Leukocytes are targeted to the liver sinusoids by chemoattractants and, like platelets, tether to the sinusoidal endothelial cells, which are in a procoagulant state of inflammatory activation. Clogging of the sinusoids by these cells leads to a decrease of blood flow through the sinusoids, which is further aggravated by endothelin-1 effectuating the constriction of hepatic stellate cells in the sinusoids. In contrast, both nitric oxide (NO) and carbon monoxide (CO) act as antagonists of endothelin-1 by mediating relaxation of sinusoidal vessels. By maintaining an adequate sinusoidal perfusion, both NO and CO are hepatoprotective during the early, hyperdynamic phase of sepsis characterized by an increased cardiac output and moderate peripheral vasodilation. However, during the late, hypodynamic phase of sepsis, massive overproduction of NO by the inducible NO synthase leads to circulatory collapse, which inevitably includes breakdown of the liver circulation.

KEYWORD

Liver - sepsis - microcirculation - sinusoids - endothelial cells

REFERENCES

  • 1 Bone R C. Gram-positive organisms and sepsis.  Arch Intern Med . 1994;  154 26-34
    CrossrefPubMedGoogle Scholar
  • 2 Rackow E C, Astiz M E. Pathophysiology and treatment of septic shock.  JAMA . 1991;  266 548-554
    CrossrefPubMedGoogle Scholar
  • 3 Wang P, Chaudry I CH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis.  Am J Physiol . 1996;  270 R927-R938
    PubMedGoogle Scholar
  • 4 Pfeiffer R. Untersuchungen über das Choleragift.  Z Hyg . 1892;  11 393-412
    PubMedGoogle Scholar
  • 5 Morrison D C, Silverstein R, Luchi M, Shnyra A. Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis.  Infect Dis Clin North Am . 1999;  13 313-340
    CrossrefPubMedGoogle Scholar
  • 6 De Kimpe J S, Kengatharan M, Thiemermann C, Vane J R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.  Proc Natl Acad Sci USA . 1995;  92 10359-10363
    PubMedGoogle Scholar
  • 7 Braun J S, Novak R, Gao G, Murray P J, Shenep J L. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages.  Infect Immunol . 1999;  67 3750-3756
    PubMedGoogle Scholar
  • 8 Suttorp N, Fuhrmann M, Tannert-Otto S, Grimminger F, Bhadki S. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells.  J Exp Med . 1993;  178 337-341
    CrossrefPubMedGoogle Scholar
  • 9 Fleischer B. Pyrogenic exotoxins (superantigens) (Staphylococcus aureus and Streptococcus pyogenes). In: Rappuoli R, Montecucco C, eds. Guidebook to Protein Toxins and Their Use in Cell Biology Oxford: Oxford University Press, 1997: 89-91
    Google Scholar
  • 10 Sparwasser T, Miethke T, Lipford G. Bacterial DNA causes septic shock.  Nature . 1997;  386 336-337
    CrossrefPubMedGoogle Scholar
  • 11 Lipford G B, Heeg K, Wagner H. Bacterial DNA as immune cell activator.  Trends Microbiol . 1998;  6 496-500
    CrossrefPubMedGoogle Scholar
  • 12 Michie H R, Manogue K R, Spriggs D R. Detection of circulating tumor necrosis factor after endotoxin administration.  N Engl J Med . 1988;  318 1481-1486
    CrossrefPubMedGoogle Scholar
  • 13 Damas P, Reuter A, Gysen P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.  Crit Care Med . 1989;  17 975-978
    CrossrefPubMedGoogle Scholar
  • 14 Tsutsui H, Matsui K, Kawada N. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.  J Immunol . 1997;  159 3961-3967
    PubMedGoogle Scholar
  • 15 Tsutsui H, Kayagaki N, Kuida K. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.  Immunity . 1999;  11 359-367
    CrossrefPubMedGoogle Scholar
  • 16 Hack C E, De Groot R E, Felt-Bersma R J. Increased plasma levels of interleukin-6 in sepsis.  Blood . 1989;  74 1704-1710
    PubMedGoogle Scholar
  • 17 Ohteki T, Okamoto S, Nakamura M, Nemoto E, Kumagai K. Elevated production of interleukin 6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice.  Immunol Lett . 1993;  36 145-152
    CrossrefPubMedGoogle Scholar
  • 18 Rietschel E T, Mamat U, Ulmer A J. Bakterielle Endotoxine als Auslöser des septischen Schocks: Konstitution, Wirkung und Neutralisation. In: Lode H, Siegenthaler W, eds. Neue Erkenntnisse in der Infektiologie New York: Thieme, 1999: 61-87
    Google Scholar
  • 19 Ayala A, Knotts J B, Ertel W. Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis.  Arch Surg . 1993;  128 89-94
    PubMedGoogle Scholar
  • 20 Knolle P A, Loser E, Protzer U. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10.  Clin Exp Immunol . 1997;  107 555-561
    CrossrefPubMedGoogle Scholar
  • 21 Kox W J, Bone R C, Krausch D. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: Proof of principle.  Arch Intern Med . 1997;  157 389-393
    CrossrefPubMedGoogle Scholar
  • 22 Bucher M, Ittner K P, Zimmermann M. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid.  FEBS Lett . 1997;  412 511-514
    CrossrefPubMedGoogle Scholar
  • 23 Wong J M, Billiar T R. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation.  Adv Pharmacol . 1995;  34 155-170
    PubMedGoogle Scholar
  • 24 Hutcheson I R, Whittle B JR, Boughton-Smith N K. Role of nitric oxide in maintaining vascular integrity of endotoxin-induced acute intestinal damage in the rat.  Br J Pharmacol . 1992;  101 815-820
    PubMedGoogle Scholar
  • 25 Pastor C M, Losser M R, Payen D. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits.  Hepatology . 1995;  22 1547-1553
    CrossrefPubMedGoogle Scholar
  • 26 Losser M R, Payen D. Mechanisms of liver damage.  Semin Liver Dis . 1996;  16 357-367
    PubMedGoogle Scholar
  • 27 Bauer M, Zhang J X, Bauer I, Clemens M G. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action.  Am J Physiol . 1994;  267 G143-G149
    PubMedGoogle Scholar
  • 28 McCuskey R S. Responses of the hepatic sinusoid lining and microcirculation to combinations of endotoxin, cytokines and ethanol. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the Hepatic Sinusoid III Leiden: Kupffer Cell Foundation, 1991: 1-5
    Google Scholar
  • 29 Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells.  Am J Physiol . 1996;  270 G660-G666
    PubMedGoogle Scholar
  • 30 Meszaros K, Bojta J, Bautista A P, Lang C H, Spitzer J J. Glucose utilization by Kupffer cells, endothelial cells, and granulocytes in endotoxemic rat liver.  Am J Physiol . 1991;  260 G7-G12
    PubMedGoogle Scholar
  • 31 Doi F, Goya T, Torisu M. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis.  Hepatology . 1993;  17 1086-1094
    CrossrefPubMedGoogle Scholar
  • 32 McCuskey R S, Nishida J, McDonnell D. Effect of immunoglobulin G on the hepatic microvascular inflammatory response during sepsis.  Shock . 1996;  5 28-33
    PubMedGoogle Scholar
  • 33 Steinhoff G, Behrend M, Schrader B, Duijvestijn A M, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3.  Am J Pathol . 1993;  142 481-488
    PubMedGoogle Scholar
  • 34 Xu H, Gonzalo J A, St Pierre Y. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice.  J Exp Med . 1994;  180 95-109
    CrossrefPubMedGoogle Scholar
  • 35 Wang P, Ayala A, Ba Z F. Tumor necrosis factor-α produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation.  Am J Physiol . 1993;  265 G126-G132
    PubMedGoogle Scholar
  • 36 Wang J H, Redmond H P, Watson R WG, Bouchier-Hayes D. Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis.  Am J Physiol . 1995;  269 G297-G304
    PubMedGoogle Scholar
  • 37 Wang P, Ba Z F, Chaudry I H. Mechanism of hepatocellular dysfunction during early sepsis.  Arch Surg . 1997;  132 364-370
    CrossrefPubMedGoogle Scholar
  • 38 Wang P, Ba Z F, Chaudry I H. Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis.  Shock . 1995;  3 21-26
    PubMedGoogle Scholar
  • 39 Wang P, Ba Z F, Chaudry I H. Nitric oxide. To block or enhance its production during sepsis?.  Arch Surg . 1994;  129 1137-1142
    PubMedGoogle Scholar
  • 40 Kilbourn R G, Szabo C, Traber D L. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.  Shock . 1997;  7 235-246
    PubMedGoogle Scholar
  • 41 Harbrecht B G, Billiar T R, Stadler J. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia.  Crit Care Med . 1992;  20 1568-1574
    PubMedGoogle Scholar
  • 42 Wang Y, Lawson J A, Jaeschke H. Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia.  Shock . 1998;  10 20-25
    PubMedGoogle Scholar
  • 43 Bauer M, Zhang J X, Bauer I, Clemens M G. Endothelin-1 as a regulator of hepatic microcirculation: Sublobular distribution of effects and impact on hepatocellular secretory function.  Shock . 1994;  1 457-465
    PubMedGoogle Scholar
  • 44 Bauer M, Zhang J X, Bauer I, Clemens M G. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action.  Am J Physiol . 1994;  267 G143-G149
    PubMedGoogle Scholar
  • 45 Sakamoto M, Ueno T, Kin M. Ito cell contraction in response to endothelin-1 and substance P.  Hepatology . 1993;  18 978-983
    PubMedGoogle Scholar
  • 46 Housset C, Rockey D C, Bissell D M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.  Proc Natl Acad Sci USA . 1993;  90 9266-9270
    CrossrefPubMedGoogle Scholar
  • 47 Rockey D C. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction.  Biochem Biophys Res Commun . 1995;  207 725-731
    CrossrefPubMedGoogle Scholar
  • 48 Ruetten H, Thiemermann C. Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat.  Br J Pharmacol . 1996;  119 479-486
    PubMedGoogle Scholar
  • 49 Higuchi H, Satoh T. Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ET(B) receptors in isolated perfused rat liver.  Eur J Pharmacol . 1997;  328 175-182
    CrossrefPubMedGoogle Scholar
  • 50 Suematsu M, Goda N, Sano T. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver.  J Clin Invest . 1995;  96 2431-2437
    PubMedGoogle Scholar
  • 51 Downard P J, Wilson M A, Spain D A. Heme oxygenase-dependent carbon monoxide production is a hepatic adaptive response to sepsis.  J Surg Res . 1997;  71 7-12
    CrossrefPubMedGoogle Scholar